SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-20-001201
Filing Date
2020-04-24
Accepted
2020-04-24 16:45:43
Documents
4
Period of Report
2020-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c95791_8k.htm 8-K 15342
2 c95791_ex99-1.htm EX-99.1 51611
3 GRAPHIC x1_c95791a001.jpg GRAPHIC 6738
4 GRAPHIC x1_c95791a002.jpg GRAPHIC 4626
  Complete submission text file 0000930413-20-001201.txt   84141
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 20815682
SIC: 8071 Services-Medical Laboratories